Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Fruquintinib for Colorectal Cancer
Recruiting1 awardPhase 3
Dallas, Texas
This trial tests fruquintinib, a drug that blocks signals making cancer cells grow, in patients with advanced colorectal cancer who haven't responded to other treatments. Fruquintinib is a drug that blocks signals making cancer cells grow and has shown significant benefits in previous trials for certain types of lung cancer. It aims to find new options for those whose cancer continues to progress despite other treatments.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service